GE HealthCare has announced Vscan Air SL a handheld, wireless ultrasound imaging system designed for cardiac and vascular assessments at point of care to help clinicians accelerate diagnoses and treatment decisions. The recent addition to Vscan product suite, Vscan Air SL features GE Healthcare’s proprietary SignalMax and XDclear technology that provide high levels of penetration, resolution, and sensitivity in imaging performance with single crystal transducer technology.
With cardiovascular disease spreading worldwide often presenting in emergency situations, prompt diagnosis and treatment can be vital. The portable, wireless Vscan Air SL is designed to enable clinicians to collect and view crystal clear cardiac and vascular images at point of care. By streamlining these workflows and avoiding overloading traditional radiology resources, clinicians can expedite care decisions to help patients receive treatment plans right away when time is of essence.
“Having ever more powerful handheld ultrasound is a game changer for patient care. Whether on the ward or in general practice, being able to provide high-quality imaging at the point of care means rapid diagnosis and rapid treatment.” says Guy Lloyd, consultant cardiologist and clinical director for cardiovascular diagnostics and investigations at Barts Heart Center, University College London Hospitals.
With Vscan Air SL, clinicians have a pocket-sized, portable tool that allows for clear, whole-body scanning and secure viewing of images. In addition, through Vscan Air + Digital Tools, clinicians have access to subscriptions that can connect them to a suite of easy-to-use solutions designed to improve workflow with secure collaboration, image, and device management features.
“Vscan Air SL enables clinicians to make quick cardiac assessments and adds to our broad portfolio of ultrasound technologies to help further inform clinical decision making at point of care. This newest innovation demonstrates our commitment to providing integrated solutions resulting in better standard of care delivery and ultimately helping clinicians improve patient outcomes.” says Dietmar Seifriedsberger, global general manager, point of care and handheld ultrasound at GE HealthCare.
GE Healthcare developed its colour pocket-sized ultrasound, Vscan, in 2010 and has since continued to modernise way clinicians treat patients. In 2021, GE HealthCare introduced one of the lightweight handheld ultrasound devices with Vscan Air CL. To date, there are more than 50,000 systems from Vscan product suite in pockets of clinicians, impacting care of more than an estimated 100 million patients worldwide. Vscan Air CL and SL continue company’s commitment to transform clinical exam by making it easier to acquire high quality ultrasound images.
GE HealthCare is showcasing Vscan Air SL at European Society of Cardiology (ESC) 2023 annual meeting in Amsterdam, Netherlands Friday, August 25 Monday, August 28 in booth #H500. The booth features the theme “Know. Now.” with information and resources to raise awareness of the importance of early detection of cardiovascular disease for better patient outcomes.
Vscan Air SL is currently commercially available in countries throughout Europe and Asia as well as Australia and New Zealand. In United States, Vscan Air SL is 510(k) cleared by US Food and Drug Administration and will become commercially available this quarter.
For more information about GE HealthCare Vscan Air wireless handheld ultrasound, please visit here.
Comment on this article below or via Twitter: @IoTNow_OR @jcIoTnow
